BWX Technologies (BWXT) Stock Forecast & Price Target

BWX Technologies is well positioned by its sole-source role for U.S. Navy nuclear reactors and fuel, the 30-year shipbuilding plan, and backlog that has more than doubled to $8.4B as of 2Q26, providing unusually durable revenue visibility. Its Commercial Operations arm is also scaling quickly, with revenue rising from about $330M in 2020 to more than $1.1B in 2026 and a $1.6B commercial backlog, supported by CANDU life extensions, AP1000 and SMR opportunities, and broader international project exposure. Management’s 2026 guidance of roughly $3.80B revenue, $662M-$672M adjusted EBITDA, and $345M-$360M free cash flow, along with 2030 targets of $5.5B-$6.0B revenue and $1.1B-$1.2B adjusted EBITDA, reinforces a strong long-term growth and cash-generation outlook.

BWX Technologies is viewed cautiously because its core Government Operations business, while predictable, is heavily dependent on U.S. Navy and DoD/DoE spending, leaving results exposed to funding cuts, contract changes, or shifts in government buying patterns. Although the 2026 Investor Day reinforced expansion across the nuclear value chain and management reiterated 2026 guidance while outlining a 2027 framework, the analysis suggests the stock already prices in much of the upside from emerging mobile reactors and medical isotopes. With a 2027 EPS estimate of $5.05 and valuation judged optimistic, the 2027 and 2030 growth paths appear vulnerable to lower-than-expected adoption or delays in commercialization.